SAD Study Synopsis (OBX-319)

Document ID: CSR-101
Version: 1.0
Change History: 1.0 — Initial issue.
Standard(s): ICH E3

Supporting Study — First-in-Human SAD Synopsis — OBX-319

Synopsis of the single-ascending-dose study of OBX-319: safety, tolerability, and initial pharmacokinetics in healthy participants supporting dose escalation. ICH E3 (synopsis).